BRG1 overexpression, reduced orabsent PTEN expression and elevated cyclin D1 levels were correlated in35% of CRC primary tumors, suggesting misregulation of this pathwayin a sizable number of CRC patients [98]. The gene discussed is PTEN; the disease is colorectal carcinoma.